美敦力公司（MEDTRONIC）2025财年第二季度财报（英文版）（25页）.pdf

1、Q2 FY25Earnings PresentationNovember 19,2024Forward Looking StatementsThis presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995,which are subject to risks and uncertainties,including risks related to competitive factors,difficult

2、ies and delays inherent in the development,manufacturing,marketing and sale of medical products,government regulation,geopolitical conflicts,general economic conditions,and other risks and uncertainties described in the companys periodic reports on file with the US Securities and Exchange Commission

3、 including the most recent Annual Report on Form 10-K of the company.Actual results may differ materially from anticipated results.Medtronic does not undertake to update its forward-looking statements or any of the information contained in this presentation,including to reflect future events or circ

4、umstances.Non-GAAP financial measuresCertain information in this presentation includes calculations or figures that have been prepared internally and have not been reviewed or audited by our independent registered public accounting firm.Use of different methods for preparing,calculating or presentin

5、g information may lead to differences and such differences may be material.This presentation contains financial measures and guidance which are considered“non-GAAP”financial measures under applicable SEC rules and regulations.Medtronic management believes that non-GAAP financial measures provide inf

6、ormation useful to investors in understanding the companys underlying operational performance and trends and to facilitate comparisons with the performance of other companies in the med tech industry.Non-GAAP financial measures should be considered supplemental to and not a substitute for financial